Biovica International AB Statistics

Total Valuation

STO:BIOVIC.B has a market cap or net worth of SEK 68.25 million. The enterprise value is 30.86 million.

Market Cap	68.25M
Enterprise Value	30.86M

Important Dates

The next estimated earnings date is Wednesday, June 18, 2025.

Earnings Date	Jun 18, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:BIOVIC.B has 97.79 million shares outstanding. The number of shares has increased by 76.72% in one year.

Current Share Class	n/a
Shares Outstanding	97.79M
Shares Change (YoY)	+76.72%
Shares Change (QoQ)	+7.67%
Owned by Insiders (%)	17.08%
Owned by Institutions (%)	11.06%
Float	72.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.33
PB Ratio	1.06
P/TBV Ratio	1.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.29
EV / Sales	3.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.33

Financial Position

The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.09.

Current Ratio	2.73
Quick Ratio	2.64
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-76.10

Financial Efficiency

Return on equity (ROE) is -106.13% and return on invested capital (ROIC) is -63.14%.

Return on Equity (ROE)	-106.13%
Return on Assets (ROA)	-55.31%
Return on Invested Capital (ROIC)	-63.14%
Return on Capital Employed (ROCE)	-157.88%
Revenue Per Employee	315,038
Profits Per Employee	-4.09M
Employee Count	32
Asset Turnover	0.07
Inventory Turnover	0.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.45% in the last 52 weeks. The beta is 1.80, so STO:BIOVIC.B's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	-58.45%
50-Day Moving Average	1.28
200-Day Moving Average	2.07
Relative Strength Index (RSI)	35.16
Average Volume (20 Days)	194,786

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:BIOVIC.B had revenue of SEK 8.19 million and -106.39 million in losses. Loss per share was -1.21.

Revenue	8.19M
Gross Profit	6.88M
Operating Income	-108.52M
Pretax Income	-106.58M
Net Income	-106.39M
EBITDA	-107.81M
EBIT	-108.52M
Loss Per Share	-1.21

Full Income Statement

Balance Sheet

The company has 43.51 million in cash and 6.12 million in debt, giving a net cash position of 37.39 million or 0.38 per share.

Cash & Cash Equivalents	43.51M
Total Debt	6.12M
Net Cash	37.39M
Net Cash Per Share	0.38
Equity (Book Value)	64.46M
Book Value Per Share	0.66
Working Capital	31.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -92.79 million and capital expenditures -355,000, giving a free cash flow of -93.15 million.

Operating Cash Flow	-92.79M
Capital Expenditures	-355,000
Free Cash Flow	-93.15M
FCF Per Share	-0.95

Full Cash Flow Statement

Margins

Gross Margin	84.04%
Operating Margin	-1,324.82%
Pretax Margin	-1,301.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:BIOVIC.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-76.72%
Shareholder Yield	-76.72%
Earnings Yield	-155.87%
FCF Yield	-136.47%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:BIOVIC.B has an Altman Z-Score of -6.59. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.59
Piotroski F-Score	n/a